161 related articles for article (PubMed ID: 27393599)
21. The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study.
Zhou X; Zheng Z; Li Y; Zhao W; Lin Y; Zhang J; Sun Q
BMC Cancer; 2021 May; 21(1):536. PubMed ID: 33975551
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study.
Rakha EA; Tan PH; Varga Z; Tse GM; Shaaban AM; Climent F; van Deurzen CH; Purnell D; Dodwell D; Chan T; Ellis IO
Br J Cancer; 2015 Jan; 112(2):283-9. PubMed ID: 25422911
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological Features and Prognosis of Metaplastic Breast Carcinoma: Experience of a Major Chinese Cancer Center.
Zhang Y; Lv F; Yang Y; Qian X; Lang R; Fan Y; Liu F; Li Y; Li S; Shen B; Pringle GA; Zhang X; Fu L; Guo X
PLoS One; 2015; 10(6):e0131409. PubMed ID: 26115045
[TBL] [Abstract][Full Text] [Related]
24. Competing Risk Analyses of Medullary Carcinoma of Breast in Comparison to Infiltrating Ductal Carcinoma.
Dai D; Shi R; Wang Z; Zhong Y; Shin VY; Jin H; Wang X
Sci Rep; 2020 Jan; 10(1):560. PubMed ID: 31953417
[TBL] [Abstract][Full Text] [Related]
25. Hormone Receptor Status May Impact the Survival Benefit Between Medullary Breast Carcinoma and Atypical Medullary Carcinoma of the Breast: A Population-Based Study.
Qin W; Qi F; Guo M; Wang L; Zang YS
Front Oncol; 2021; 11():677207. PubMed ID: 34295817
[TBL] [Abstract][Full Text] [Related]
26. Medullary carcinoma of the breast: ten year clinical experience of the Kuwait cancer control centre.
Samir SM; Fayaz MS; Elbasmi A; Motawy MM; Abuzallouf S; George T; Abdelhady M; Bedair A
Gulf J Oncolog; 2011 Jul; (10):45-52. PubMed ID: 21724529
[TBL] [Abstract][Full Text] [Related]
27. Hormone receptor status and survival of medullary breast cancer patients. A Turkish cohort.
Aksoy A; Odabas H; Kaya S; Bozkurt O; Degirmenci M; Topcu TO; Aytekin A; Arpaci E; Avci N; Pilanci KN; Cinkir HY; Bozkaya Y; Cirak Y; Gumus M
Saudi Med J; 2017 Feb; 38(2):156-162. PubMed ID: 28133688
[TBL] [Abstract][Full Text] [Related]
28. Gender differences in breast cancer: analysis of 13,000 breast cancers in men from the National Cancer Data Base.
Greif JM; Pezzi CM; Klimberg VS; Bailey L; Zuraek M
Ann Surg Oncol; 2012 Oct; 19(10):3199-204. PubMed ID: 22766989
[TBL] [Abstract][Full Text] [Related]
29. Medullary breast carcinoma: a pathogenic review and immunohistochemical study using tissue microarray.
Lee M; Jara-Lazaro AR; Cheok PY; Thike AA
Singapore Med J; 2022 Jul; 63(7):394-401. PubMed ID: 33866710
[TBL] [Abstract][Full Text] [Related]
30. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.
Gokce H; Durak MG; Akin MM; Canda T; Balci P; Ellidokuz H; Demirkan B; Gorken IB; Sevinc AI; Kocdor MA; Saydam S; Harmancioglu O
Breast J; 2013; 19(4):374-81. PubMed ID: 23714006
[TBL] [Abstract][Full Text] [Related]
31. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06).
Yu JI; Choi DH; Huh SJ; Cho EY; Kim K; Chie EK; Ha SW; Park IA; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Koo JS; Kim JH; Jeong BG; Kim IA; Lee JH; Park W
Clin Breast Cancer; 2015 Oct; 15(5):353-61.e1-2. PubMed ID: 25776197
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
[TBL] [Abstract][Full Text] [Related]
33. The prognostic significance of molecular subtype for male breast cancer: a 10-year retrospective study.
Yu XF; Feng WL; Miao LL; Chen B; Yang HJ
Breast; 2013 Oct; 22(5):824-7. PubMed ID: 23466329
[TBL] [Abstract][Full Text] [Related]
34. Prognosis of Medullary Carcinoma of the Breast: 10 years' Experience in a Single Institution.
Kouhen F; Benhmidou N; Afif M; Rais F; Khamou M; Khanoussi B; El Menaoui O; Elkacemi H; Elmajjaoui S; Kebdani T; Benjaafar N
Breast J; 2017 Jan; 23(1):112-114. PubMed ID: 27671230
[No Abstract] [Full Text] [Related]
35. High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma.
Jacquemier J; Bertucci F; Finetti P; Esterni B; Charafe-Jauffret E; Thibult ML; Houvenaeghel G; Van den Eynde B; Birnbaum D; Olive D; Xerri L
Int J Cancer; 2012 Jan; 130(1):96-104. PubMed ID: 21328335
[TBL] [Abstract][Full Text] [Related]
36. Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis.
Nelson RA; Guye ML; Luu T; Lai LL
Ann Surg Oncol; 2015 Jan; 22(1):24-31. PubMed ID: 25012264
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base.
Mateo AM; Pezzi TA; Sundermeyer M; Kelley CA; Klimberg VS; Pezzi CM
Ann Surg Oncol; 2017 Apr; 24(4):1050-1056. PubMed ID: 27807728
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic Characteristics and Prognosis of Invasive Papillary Carcinoma of the Breast.
Huang K; Appiah L; Mishra A; Bagaria SP; Gabriel ME; Misra S
J Surg Res; 2021 May; 261():105-112. PubMed ID: 33422900
[TBL] [Abstract][Full Text] [Related]
39. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
40. Novel prognostic markers for patients with triple-negative breast cancer.
Zhou L; Li K; Luo Y; Tian L; Wang M; Li C; Huang Q
Hum Pathol; 2013 Oct; 44(10):2180-7. PubMed ID: 23845466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]